TAVALISSE
Identification of Tavalisse
| No description |
Google image searchProduct monograph
Active ingredient
fostamatinib (fostamatinib disodium), 150 MG
DIN: 02508060
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: MEDISON PHARMA CANADA INC.
Date: 04-JUL-2022
ATC:
- B02 — ANTIHEMORRHAGICS (ATC, ATC/DDD, )
- B02B — VITAMIN K AND OTHER HEMOSTATICS (ATC, ATC/DDD)
- B02BX — Other systemic hemostatics (ATC, ATC/DDD)
- B02BX09 — FOSTAMATINIB (ATC/DDD)
Reference brand drug: Tavalisse
